Literature DB >> 9212077

New directions in breast cancer research.

S R Wolman1, G H Heppner, E Wolman.   

Abstract

Research in breast cancer extends in many directions, stimulated by concerns related to the high incidence of the disease and the relative unpredictability of its clinical course. Examples of work in several directions are presented here arranged by four levels of analysis. 1) Molecular, intracellular events (molecular genetics). Recent identification of genes that predispose to breast cancer, and the isolation of those genes and their protein products, permit investigations of the most critical issues: the roles of these genes in normal development and breast differentiation, and how their alteration permits or contributes to tumor initiation. Thus, we expect that understanding the functions of the genes involved in inherited susceptibility to breast cancer will also be informative for sporadic breast cancers. 2) Cellular biology (cellular models for preneoplastic disease). We examine models of breast cancer development and ask how they help to validate a morphologic sequence for human breast neoplasia and whether they permit investigation of how to modify disease progression. Two useful models, one in transgenic mice and the other using human breast stem cells capable of culture and xenograft growth, are now available. 3) Tissue and organ (the tumor and its local environment). We look at the relationship of the tumor cell population to its local environment (stroma, blood vessels, etc.). This leads naturally to questions of how neighboring tissues and cytokines may modify tumor growth. 4) The individual as an organism and member of a population (hormonal rise and chemoprevention). We address identification of the primarily hormonal risk factors and a possible related mode of cancer prevention.

Entities:  

Mesh:

Year:  1997        PMID: 9212077     DOI: 10.1096/fasebj.11.7.9212077

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  4 in total

1.  Loss of immunoreactivity for human calmodulin-like protein is an early event in breast cancer development.

Authors:  M S Rogers; M A Foley; T B Crotty; L C Hartmann; J N Ingle; P C Roche; E E Strehler
Journal:  Neoplasia       Date:  1999-08       Impact factor: 5.715

Review 2.  The role of stroma in breast carcinoma growth in vivo.

Authors:  A Noël; J M Foidart
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-04       Impact factor: 2.673

Review 3.  Murine mentors: transgenic and knockout models of surgical disease.

Authors:  J M Arbeit; R Hirose
Journal:  Ann Surg       Date:  1999-01       Impact factor: 12.969

4.  Molecular characterization of lung dysplasia induced by c-Raf-1.

Authors:  Astrid Rohrbeck; Volker Steffen Müller; Jürgen Borlak
Journal:  PLoS One       Date:  2009-05-20       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.